Found: 75
Select item for more details and to access through your institution.
Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells.
- Published in:
- Scientific Reports, 2015, p. 13313, doi. 10.1038/srep13313
- By:
- Publication type:
- Article
A Novel Approach: Investigating the Intracellular Clearance Mechanism of Glyceraldehyde-Derived Advanced Glycation End-Products Using the Artificial Checkpoint Kinase 1 d270KD Mutant as a Substrate Model.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 24, p. 2838, doi. 10.3390/cells12242838
- By:
- Publication type:
- Article
Effects of Toxic AGEs (TAGE) on Human Health.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142178
- By:
- Publication type:
- Article
The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells.
- Published in:
- Nutrients, 2022, v. 14, n. 5, p. N.PAG, doi. 10.3390/nu14050990
- By:
- Publication type:
- Article
Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62.
- Published in:
- Nutrients, 2022, v. 14, n. 2, p. 332, doi. 10.3390/nu14020332
- By:
- Publication type:
- Article
Protective Effects of Collagen Tripeptides in Human Aortic Endothelial Cells by Restoring ROS-Induced Transcriptional Repression.
- Published in:
- Nutrients, 2021, v. 13, n. 7, p. 2226, doi. 10.3390/nu13072226
- By:
- Publication type:
- Article
Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model.
- Published in:
- Nutrients, 2021, v. 13, n. 1, p. 80, doi. 10.3390/nu13010080
- By:
- Publication type:
- Article
The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells.
- Published in:
- Nutrients, 2020, v. 12, n. 10, p. 2958, doi. 10.3390/nu12102958
- By:
- Publication type:
- Article
Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver.
- Published in:
- Nutrients, 2019, v. 11, n. 7, p. 1612, doi. 10.3390/nu11071612
- By:
- Publication type:
- Article
The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review.
- Published in:
- Nutrients, 2019, v. 11, n. 2, p. 462, doi. 10.3390/nu11020462
- By:
- Publication type:
- Article
Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.
- Published in:
- Nutrients, 2017, v. 9, n. 6, p. 634, doi. 10.3390/nu9060634
- By:
- Publication type:
- Article
Receptor for Advanced Glycation End Products Is a Promising Target of Diabetic Nephropathy.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1043, n. 1, p. 562, doi. 10.1196/annals.1333.064
- By:
- Publication type:
- Article
Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).
- Published in:
- Heart & Vessels, 2016, v. 31, n. 10, p. 1583, doi. 10.1007/s00380-015-0773-y
- By:
- Publication type:
- Article
Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39202-5
- By:
- Publication type:
- Article
Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis.
- Published in:
- Diabetology & Metabolic Syndrome, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13098-021-00685-w
- By:
- Publication type:
- Article
Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle.
- Published in:
- Diabetology & Metabolic Syndrome, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13098-020-00614-3
- By:
- Publication type:
- Article
Proteasome inhibition induces selective motor neuron death in organotypic slice cultures.
- Published in:
- Journal of Neuroscience Research, 2005, v. 82, n. 4, p. 443, doi. 10.1002/jnr.20665
- By:
- Publication type:
- Article
DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy.
- Published in:
- Diabetes, 2013, v. 62, n. 9, p. 3241, doi. 10.2337/db12-1608
- By:
- Publication type:
- Article
RAGE Control of Diabetic Nephropathy in a Mouse Model.
- Published in:
- Diabetes, 2006, v. 55, n. 9, p. 2510, doi. 10.2337/db06-0221
- By:
- Publication type:
- Article
Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes.
- Published in:
- Diabetes, 2006, v. 55, n. 8, p. 2245, doi. 10.2337/db05-1375
- By:
- Publication type:
- Article
Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4861, doi. 10.3390/ijms21144861
- By:
- Publication type:
- Article
Glyceraldehyde-derived advanced glycation end products in Alzheimer’s disease.
- Published in:
- Acta Neuropathologica, 2004, v. 108, n. 3, p. 189, doi. 10.1007/s00401-004-0871-x
- By:
- Publication type:
- Article
Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice.
- Published in:
- Genes to Cells, 2008, v. 13, n. 11, p. 1159, doi. 10.1111/j.1365-2443.2008.01234.x
- By:
- Publication type:
- Article
Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2014, v. 21, n. 2, p. 134, doi. 10.1002/jhbp.12
- By:
- Publication type:
- Article
Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.
- Published in:
- Journal of Ophthalmology, 2010, p. 1, doi. 10.1155/2010/170393
- By:
- Publication type:
- Article
Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. 249, doi. 10.1111/j.1755-5922.2011.00264.x
- By:
- Publication type:
- Article
Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 1, p. 42, doi. 10.1111/j.1755-5922.2010.00177.x
- By:
- Publication type:
- Article
Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions.
- Published in:
- Journal of Investigative Dermatology, 2004, v. 122, n. 2, p. 461, doi. 10.1046/j.0022-202X.2004.22218.x
- By:
- Publication type:
- Article
Toxic Advanced Glycation End-Products Inhibit Axonal Elongation Mediated by β-Tubulin Aggregation in Mice Optic Nerves.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 13, p. 7409, doi. 10.3390/ijms25137409
- By:
- Publication type:
- Article
Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2006, v. 21, n. 3, p. 197, doi. 10.1177/1533317506289277
- By:
- Publication type:
- Article
Calcium Channel Blocker Inhibition of AGE and RAGE Axis Limits Renal Injury in Nondiabetic Patients With Stage I or II Chronic Kidney Disease.
- Published in:
- Clinical Cardiology, 2011, v. 34, n. 6, p. 372, doi. 10.1002/clc.20885
- By:
- Publication type:
- Article
Low-Density Lipoprotein Levels are One of the Independent Determinants of Circulating Levels of Advanced Glycation End Products in Nondiabetic Subjects.
- Published in:
- Clinical Cardiology, 2009, v. 32, n. 9, p. E12, doi. 10.1002/clc.20532
- By:
- Publication type:
- Article
Vardenafil, an inhibitor of phosphodiesterase-5, blocks advanced glycation end product (AGE)-induced up-regulation of monocyte chemoattractant protein-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression via elevation of cGMP.
- Published in:
- Clinical & Experimental Medicine, 2011, v. 11, n. 2, p. 131, doi. 10.1007/s10238-010-0109-2
- By:
- Publication type:
- Article
An α-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46333-2
- By:
- Publication type:
- Article
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.
- Published in:
- Diagnostics (2075-4418), 2016, v. 6, n. 2, p. 23, doi. 10.3390/diagnostics6020023
- By:
- Publication type:
- Article
Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070034
- By:
- Publication type:
- Article
Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 202, doi. 10.3390/biom14020202
- By:
- Publication type:
- Article
Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 3, p. 387, doi. 10.3390/biom11030387
- By:
- Publication type:
- Article
Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2014, v. 30, n. 8, p. 693, doi. 10.1002/dmrr.2537
- By:
- Publication type:
- Article
Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2013, v. 29, n. 8, p. 624, doi. 10.1002/dmrr.2437
- By:
- Publication type:
- Article
Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2013, v. 29, n. 5, p. 406, doi. 10.1002/dmrr.2407
- By:
- Publication type:
- Article
Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
- Published in:
- Diabetes/Metabolism Research & Reviews, 2009, v. 25, n. 3, p. 266, doi. 10.1002/dmrr.906
- By:
- Publication type:
- Article
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2008, v. 24, n. 2, p. 109, doi. 10.1002/dmrr.766
- By:
- Publication type:
- Article
RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82619-0
- By:
- Publication type:
- Article
Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.921611
- By:
- Publication type:
- Article
Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2007, v. 22, n. 7, p. 1112, doi. 10.1111/j.1440-1746.2007.04943.x
- By:
- Publication type:
- Article